Trial Profile
Efficacy of Ibrutinib Therapy in Various B-cell Malignancies in the General Community
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia; Lymphoma; Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 11 May 2018 New trial record